Published • loading... • Updated
Sam Altman Is Investing $180 Million of His Own Money in an Ambitious Startup that Aims to "Rejuvenate" Human Cells to Slow Aging and Disease in People over 50.
Summary by agron.com.br
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Explore the Agron Portal and stay updated on agribusiness, science, and economics. Discover the knowledge that drives your success! While the world focused on artificial intelligence, Sam Altman quietly began betting on another technological race that could completely change medicine. For years, the name Sam Altman has been almost exclusively associated with artificial intelligence. The CEO of OpenAI became a symbol of the global explosion of Ch…
·Dourados, Brazil
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
